A Dose Escalation Study of FP-045 in Patients With Fanconi Anemia

NCT04522375 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class

Stopped Twenty months after investigative site initiations, and best efforts to identify study participants, no participants were identified.

Conditions

Interventions

Sponsor

Foresee Pharmaceuticals Co., Ltd.